Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
Clinical trial NCT04598269 · COMPLETED
Trial details
- NCT number
- NCT04598269
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2021-04-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.